Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1.
Zhao Z, Li X, El-Battrawy I, Lan H, Zhong R, Xu Q, Huang M, Liao Z, Lang S, Zimmermann WH, Cyganek L, Wieland T, Akin I, Zhou XB, Borggrefe M.
Zhao Z, et al. Among authors: borggrefe m.
Clin Pharmacol Ther. 2019 Sep;106(3):642-651. doi: 10.1002/cpt.1449. Epub 2019 May 13.
Clin Pharmacol Ther. 2019.
PMID: 30947366